Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - atovaquone, quantity: 250 mg; proguanil hydrochloride, quantity: 100 mg - tablet - excipient ingredients: povidone; microcrystalline cellulose; poloxamer; sodium starch glycollate type a; hyprolose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 8000; iron oxide red; macrogol 400 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults.,? treatment of plasmodium falciparum malaria in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 250mg;  ; clarithromycin 250mg - film coated tablet - 250 mg - active: clarithromycin 250mg   excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol   hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - 250mg/100mg - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: hyprolose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose opadry pink oy-s-24972 poloxamer 188 povidone sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - lapatinib ditosilate monohydrate 405mg equivalent to 250 mg lapatinib free base - tablet - 250 mg - active: lapatinib ditosilate monohydrate 405mg equivalent to 250 mg lapatinib free base excipient: magnesium stearate microcrystalline cellulose opadry yellow ys-1-12524-a povidone sodium starch glycolate - her2-positive (her2+) overexpressing metastatic breast cancer tykerb, in combination with capecitabine, is indicated for the treatment of patients with advanced/metastatic breast cancer whose tumours overexpress her2 (erbb2) and whose tumours have progressed after treatment with an anthracycline and a taxane, and who have progressed on prior trastuzumab therapy in the metastatic setting. tykerb, in combination with paclitaxel, is indicated for the first-line treatment of patients with metastatic breast cancer whose tumours overexpress her2 (erbb2) and for whom trastuzumab is not appropriate. hormone receptor-positive metastatic breast cancer tykerb, in combination with an aromatase inhibitor, is indicated for the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer whose tumours overexpress her2 (erbb2) and for whom hormonal therapy is indicated.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية النابلسي - nabulsi drug store - naproxen 250 mg - 250 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ciprofloxacin hydrochloride 291mg equivalent to ciprofloxacin 250 mg, as monohydrate - film coated tablet - 250 mg - active: ciprofloxacin hydrochloride 291mg equivalent to ciprofloxacin 250 mg, as monohydrate excipient: colloidal silicon dioxide crospovidone hypromellose macrogol 4000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide - in adults uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens: infections of the lower respiratory tract.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 250 mg/5 ml - clarithromycin 250 mg/5 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - permethrin; imidacloprid - spot-on solution - 1250, 250 mg/pipette - permethrin, combinations - dogs - ectoparasiticide

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - naproxen, quantity: 250 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; maize starch; purified talc; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis, ankylosing spondylitis; symptomatic treatment of primary dysmenorrhoea, relief of acute and/or chronic pain states in which there is an inflammatory component, and as an analgesic in acute migraine attack.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - amoxicillin 250 mg/5ml, clavulanic acid 62.5 mg/5ml - 250 mg/5ml, 62.5 mg/5ml